STOCK TITAN

Terns Pharmaceuticals, Inc. (TERN) Net Income by Year

TERN

Terns Pharmaceuticals, Inc. reported a net loss of $96.2M in fiscal year 2025. This represents a decrease of 8.3% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Terns Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Net Income -$96.2M
YoY -8.3%
Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TERN Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-K
Net Income-$96.2M-8.3%-$88.9M+1.5%-$90.2M-49.5%-$60.3M-20.3%-$50.2M-25.2%-$40.1M

TERN Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-Q
Net IncomeN/A-$24.6M-12.3%-$24.1M-6.0%-$23.9M-6.9%N/A-$21.9M+26.3%-$22.7M-27.0%-$22.4M-3.9%N/A-$29.8M-77.0%-$17.9M-28.5%-$21.5M-56.3%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Terns Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was Terns Pharmaceuticals, Inc.'s net income in fiscal year 2025?

Terns Pharmaceuticals, Inc. reported a net loss of $96.2M in fiscal year 2025.

How fast is Terns Pharmaceuticals, Inc.'s net income growing?

Terns Pharmaceuticals, Inc. (TERN) net income fell by 8.3% year over year, from -$88.9M to -$96.2M in fiscal year 2025.

How has Terns Pharmaceuticals, Inc.'s net income changed over the years?

Across the 6 fiscal years this page covers, Terns Pharmaceuticals, Inc. (TERN) net income went from -$40.1M in fiscal year 2020 to -$96.2M in fiscal year 2025.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Terns Pharmaceuticals, Inc. (TERN) reported on that line in every period on record.